Imatib 100 MG Tablet contains Imatinib Mesylate 100mg, providing flexible dosing of this BCR-ABL inhibitor for patients requiring dose modification, pediatric dosing, or dose escalation titration during CML or GIST therapy.

How It Works: Imatinib blocks BCR-ABL, c-Kit, and PDGFR tyrosine kinase activity by occupying the ATP-binding cleft, preventing downstream phosphorylation events that maintain cancer cell viability.

Common Uses: Dose-adjusted CML therapy, pediatric CML, GIST with dose modification requirements, and Ph+ ALL in combination regimens.

Administration: Take with food and a glass of water. For patients unable to swallow, tablets may be dispersed in water. Follow the dose prescribed by your oncologist.

Storage: Store below 30°C in a dry place. Keep in original blister packaging and away from children.

Disclaimer: This product requires a valid prescription. Consult a licensed oncologist before use. This information is for educational purposes only.